Lupin Completes Acquisition of VISUfarma
Mumbai, London, Rome, Zug, April 2, 2026 – Lupin Limited announced the completion of its acquisition of VISUfarma B.V. (VISUfarma) from GHO Capital Partners LLP (GHO). The acquisition expands Lupin's specialty care portfolio and strengthens its presence in Europe.The integration of VISUfarma has expanded Lupin's ophthalmology portfolio to over 60 branded products spanning dry eye, glaucoma, eyelid hygiene, blepharitis, retinal health, and specialty nutraceuticals. VISUfarma has a commercial footprint across key European markets, including Italy, the UK, Spain, Germany, and France.VISUfarma generated €53 million in revenue in 2025 across Italy, the UK, Spain, Germany, France, and certain...